CONMED director Mirviss reports zero share holdings

CONMED Corp filed an initial insider ownership report for Jeffrey B. Mirviss, who became a Director on July 1, 2026.

Rhea-AI Filing Summary

CONMED Corp filed an initial insider ownership report for Jeffrey B. Mirviss, who became a Director on July 1, 2026. The filing lists his position in the company’s Common Stock.

The report shows he held 0 shares of Common Stock following the reported date, meaning no beneficial ownership is reported at this time.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Mirviss Jeffrey B.

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Direct)

Footnotes (1)

1. F1. Jeffrey B. Mirviss became a Director of CONMED on July 1, 2026.

Key Figures

Common Stock ownership: 0 shares Holding entries: 1 entry

2 metrics

Common Stock ownership 0 shares Total shares following transaction as of July 1, 2026

Holding entries 1 entry Initial ownership status reported on Form 3

Key Terms

Common Stock, Director, transaction code

3 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Director financial

"Jeffrey B. Mirviss became a Director of CONMED on July 1, 2026."

transaction code regulatory

"transaction_code_description: "Unknown transaction code""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Jeffrey B. Mirviss’s Form 3 filing show for CONMED Corp (CNMD)?

The Form 3 for Jeffrey B. Mirviss shows his initial insider ownership status in CONMED Corp. It indicates his role as a Director and reports his position in the company’s Common Stock as of July 1, 2026.

How many CONMED Corp (CNMD) shares does Jeffrey B. Mirviss report owning on Form 3?

Jeffrey B. Mirviss reports owning 0 shares of CONMED Corp Common Stock on his Form 3. The filing’s total_shares_following_transaction field for Common Stock is 0.0000, indicating no beneficial ownership reported at that time.

When did Jeffrey B. Mirviss become a Director of CONMED Corp (CNMD)?

Jeffrey B. Mirviss became a Director of CONMED Corp on July 1, 2026. This date is disclosed in a footnote, which explains that his appointment as a Director coincides with the timing of the initial Form 3 ownership report.

Does the CONMED Corp (CNMD) Form 3 for Jeffrey B. Mirviss show any stock transactions?

The Form 3 does not report any buy or sell transactions for Jeffrey B. Mirviss. Transaction fields show no purchases or sales, and his total_shares_following_transaction for Common Stock is 0.0000, reflecting only his initial ownership status.

What type of security is reported in Jeffrey B. Mirviss’s CONMED Corp (CNMD) Form 3?

The Form 3 lists CONMED Corp “Common Stock” as the security associated with Jeffrey B. Mirviss. For this security, the filing reports a total_shares_following_transaction of 0.0000, indicating no Common Stock ownership at the time of the report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 05:09 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mirviss Jeffrey B.

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FLORIDA 33773

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2026

3. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Jeffrey B. Mirviss became a Director of CONMED on July 1, 2026.

	/s/ Thomas Fistek for Jeffrey B. Mirviss by Power of Attorney	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)